Français Japonais Chinois Allemand Néerlandais Espagnol Portugais

    News

    Success story: Amaris Lille set to expand

    Switzerland-based Amaris opened an office in Hauts-de-France in late 2015. Ranked among Europe’s leading independent consulting groups, the company is growing exponentially.

    Lille shortlisted as World Design Capital 2020

    Greater Lille and Sydney are the finalists for the biennial title, awarded by the World Design Organization.

    All news

    Lille’s Macopharma uses cell therapy to fight diabetes

    07 Apr 2015 | Health Nutrition, A region on the move

    Lille-based Macopharma, a major specialist player in pharmaceuticals, has developed an automated culturing system to optimize preservation of pancreatic islets—cells that play a key role in treating diabetes.

    Macopharma innovation - Health- Lille Region

    Prisma—a pioneer in diabetes therapy

    Macopharma’s revolutionary Prisma (Pancreatic Islet System Automate unit) breaks new ground in biotherapy.  The product of four years of R&D, this new machine automatically preserves pancreatic islets, the insulin-secreting cells that are used to treat patients with type 1 diabetes.

    Patented technology, bold commercial roll-out

    Prisma uses three patented systems: a disposable medical device, a cell chamber that preserves the islets, and a specially optimized cell culture medium. “We’ve already deployed Prisma at three major cell therapy centers,” says Bruno Delorme, head of Biotherapy R&D at Macopharma. “These are Lille’s University Hospital Center (CHRU), our co-developer, plus units in Switzerland and in Sweden.

     

     

    Source: Les Echos, Nicole Buyse

     

     

    Back to news